West Pharma earnings show it's more than a GLP-1 play. Why we see more upside

October 29, 2026 • 07:11 PM

• By Harvey Stober

1 reads 0 reactions

Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

Since CNBC highlighted the stock's attractive valuation in August, shares have gained around 20%. Why we expect more upside ahead.

Tags:

#glp

Prev Swipe Story Next

Same Story from Other Publications

Compare how 3 other independent news outlets reported on this story.

3 Publications

Ars Technica

1h ago

Cost and access barriers are pushing people to modified use and unapproved versions.

#glp

CNN International

3d ago

Two doctors explain the big mistakes that cause GLP-1 side effects. Watch the full episode at CNN.com/BodyLanguage.

#glp

BBC News

3d ago

The US Food and Drug Administration says Ozempic, Wegovy, and other weight-loss drugs must have labels about the condition, known as NAION.

#glp